RSS

Aptar Pharma

Drug delivery systems provider Aptar Pharma has announced that its Bidose nasal spray device was recently approved by the U.S. FDA for a breakthrough therapy in the field of depression. Read more

News

A drug delivery systems provider will exhibit its respiratory portfolio at the Drug Delivery to the Lung (DDL) Conference 2018. Read more

News

Aptar Pharma, in combination with Schott Glass and EMA Pharmaceuticals, has announced that it will launch Aptar Pharma QuickStart for injectable drug development at CPhI Worldwide 2018, in Madrid today. Read more

News